JP2009537629A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009537629A5 JP2009537629A5 JP2009511598A JP2009511598A JP2009537629A5 JP 2009537629 A5 JP2009537629 A5 JP 2009537629A5 JP 2009511598 A JP2009511598 A JP 2009511598A JP 2009511598 A JP2009511598 A JP 2009511598A JP 2009537629 A5 JP2009537629 A5 JP 2009537629A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- men
- fispemifen
- effective amount
- urethral sphincter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 claims 2
- 208000004403 Prostatic Hyperplasia Diseases 0.000 claims 2
- 230000001684 chronic effect Effects 0.000 claims 2
- 230000004064 dysfunction Effects 0.000 claims 2
- 210000005070 sphincter Anatomy 0.000 claims 2
- 206010069918 Bacterial prostatitis Diseases 0.000 claims 1
- NKZTZAQIKKGTDB-QPLCGJKRSA-N Fispemifene Chemical compound C1=CC(OCCOCCO)=CC=C1C(\C=1C=CC=CC=1)=C(\CCCl)C1=CC=CC=C1 NKZTZAQIKKGTDB-QPLCGJKRSA-N 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 230000037396 body weight Effects 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 229940011871 estrogen Drugs 0.000 claims 1
- 239000000262 estrogen Substances 0.000 claims 1
- 229950004684 fispemifene Drugs 0.000 claims 1
- 201000007094 prostatitis Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80265706P | 2006-05-22 | 2006-05-22 | |
| US60/802,657 | 2006-05-22 | ||
| PCT/IB2007/001321 WO2007135547A2 (en) | 2006-05-22 | 2007-05-22 | Selective estrogen receptor modulators or aromatase inhibitors for treating chronic nonbacterial prostatitis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009537629A JP2009537629A (ja) | 2009-10-29 |
| JP2009537629A5 true JP2009537629A5 (enExample) | 2011-02-03 |
| JP5123935B2 JP5123935B2 (ja) | 2013-01-23 |
Family
ID=38610674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009511598A Expired - Fee Related JP5123935B2 (ja) | 2006-05-22 | 2007-05-22 | 選択的エストロゲン受容体モジュレーターまたはアロマターゼ阻害剤を用いた慢性非細菌性前立腺炎の治療方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7825107B2 (enExample) |
| EP (1) | EP2029128B1 (enExample) |
| JP (1) | JP5123935B2 (enExample) |
| KR (1) | KR101505884B1 (enExample) |
| CN (1) | CN101448490A (enExample) |
| AU (1) | AU2007252991B2 (enExample) |
| BR (1) | BRPI0712103A2 (enExample) |
| CA (1) | CA2652783C (enExample) |
| ES (1) | ES2551690T3 (enExample) |
| MX (1) | MX2008014825A (enExample) |
| NO (1) | NO341185B1 (enExample) |
| RU (1) | RU2480207C2 (enExample) |
| WO (1) | WO2007135547A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040248989A1 (en) | 2003-06-05 | 2004-12-09 | Risto Santti | Method for the treatment or prevention of lower urinary tract symptoms |
| USD784972S1 (en) | 2014-10-01 | 2017-04-25 | Samsung Electronics Co., Ltd. | Portable electronic device |
| USD779450S1 (en) | 2014-10-01 | 2017-02-21 | Samsung Electronics Co., Ltd. | Portable electronic device |
| USD781275S1 (en) | 2014-10-01 | 2017-03-14 | Samsung Electronics Co., Ltd. | Portable electronic device |
| USD803818S1 (en) | 2014-10-01 | 2017-11-28 | Samsung Electronics Co., Ltd. | Portable electronic device |
| USD779449S1 (en) | 2014-10-01 | 2017-02-21 | Samsung Electronics Co., Ltd. | Portable electronic device |
| USD795855S1 (en) | 2014-10-01 | 2017-08-29 | Samsung Electronics Co., Ltd. | Portable electronic device |
| USD797713S1 (en) | 2014-10-01 | 2017-09-19 | Samsung Electronics Co., Ltd. | Portable electronic device |
| USD785586S1 (en) | 2014-10-01 | 2017-05-02 | Samsung Electronics Co., Ltd. | Portable electronic device |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE637389A (enExample) | 1962-09-13 | |||
| US4656187A (en) * | 1981-08-03 | 1987-04-07 | Eli Lilly And Company | Treatment of mammary cancer |
| GB2126576B (en) * | 1982-06-25 | 1985-06-19 | Farmos Group Limited | Alkane and alkene derivatives |
| FI77839C (fi) | 1982-05-27 | 1989-05-10 | Farmos Oy | Foerfarande foer framstaellning av nya terapeutiskt effektiva trifenylalkan- och alkenderivat. |
| US5491173A (en) * | 1982-06-25 | 1996-02-13 | Orion-Yhtyma Oy | Tri-phenyl alkene derivatives and their preparation and use |
| US4729999A (en) * | 1984-10-12 | 1988-03-08 | Bcm Technologies | Antiestrogen therapy for symptoms of estrogen deficiency |
| EP0260066B1 (en) | 1986-09-11 | 1990-05-09 | National Research Development Corporation | Tamoxifen derivatives |
| US4869155A (en) * | 1988-07-11 | 1989-09-26 | The Grieve Corporation | Airflow distribution system for discharging air from a thin plenum, and oven employing same |
| US4977906A (en) * | 1989-03-07 | 1990-12-18 | Scipio William J Di | Diurnal rehabilitation for incontinence trainer |
| US5189212A (en) * | 1990-09-07 | 1993-02-23 | University Of Georgia Research Foundation, Inc. | Triarylethylene carboxylic acids with estrogenic activity |
| US6096874A (en) | 1990-10-01 | 2000-08-01 | Board Of Regents, The University Of Texas System | High affinity tamoxifen derivatives |
| EP0551434B1 (en) | 1990-10-01 | 1995-11-15 | The Board Of Regents, The University Of Texas System | High affinity tamoxifen derivatives and uses thereof |
| US5219548A (en) * | 1990-10-01 | 1993-06-15 | Board Of Regents, The University Of Texas System | High affinity halogenated-tamoxifen derivatives and uses thereof |
| US5118667A (en) * | 1991-05-03 | 1992-06-02 | Celtrix Pharmaceuticals, Inc. | Bone growth factors and inhibitors of bone resorption for promoting bone formation |
| US5196435A (en) * | 1991-11-21 | 1993-03-23 | Eli Lilly And Company | Melatonin derivatives and combinations with antiestrogen compounds for treating mammalian breast carcinoma |
| GB9207437D0 (en) | 1992-04-03 | 1992-05-20 | Orion Yhtymae Oy | Topical administration of toremifene and its metabolites |
| US5446203A (en) * | 1992-08-25 | 1995-08-29 | New York University | Synthesis of haloenones and aryl or alkyl substituted enones or alkenes |
| GB2273704B (en) | 1992-12-16 | 1997-01-22 | Orion Yhtymae Oy | Triazolyl diaryl selective aromatase inhibiting compounds |
| RU2077889C1 (ru) * | 1993-02-24 | 1997-04-27 | Малое государственное предприятие "Флора" | Способ лечения хронического простатита |
| DE4335876A1 (de) * | 1993-10-17 | 1995-04-20 | Schering Ag | Kombination von Progesteronantagonisten und Antiöstrogenen mit partialer agonistischer Wirkung für die Hormonsubstitutions-Therapie für peri- und postmenopausale Frauen |
| US5650425A (en) | 1994-04-04 | 1997-07-22 | Pharmos Corporation | Permanently ionic derivatives of steroid hormones and their antagonists |
| US5681835A (en) * | 1994-04-25 | 1997-10-28 | Glaxo Wellcome Inc. | Non-steroidal ligands for the estrogen receptor |
| US5604248A (en) * | 1994-05-05 | 1997-02-18 | Eli Lilly And Company | Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs |
| US5470883A (en) * | 1994-05-23 | 1995-11-28 | Stromberg; Brent V. | Method of treating peripheral vasoconstriction with tamoxifen citrate |
| US5441986A (en) * | 1994-07-19 | 1995-08-15 | Pfizer Inc. | Estrogen agonists as remedies for prostate and cardiovascular diseases |
| GB9418067D0 (en) | 1994-09-07 | 1994-10-26 | Orion Yhtymae Oy | Triphenylethylenes for the prevention and treatment of osteoporosis |
| US5658931A (en) * | 1994-09-20 | 1997-08-19 | Eli Lilly And Company | Method for inhibiting mammalian breast carcinoma with tamoxifen, and analogs thereof, and certain naphthyl compounds |
| DE4435368A1 (de) | 1994-09-22 | 1996-03-28 | Schering Ag | Verwendung von Aromatasehemmern zur Herstellung eines Arzneimittels zur Behandlung eines relativen Androgenmangels beim Mann |
| WO1996016646A1 (en) * | 1994-11-29 | 1996-06-06 | Hoechst Marion Roussel, Inc. | Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis |
| US5821254A (en) * | 1995-02-17 | 1998-10-13 | The United States Of America As Represented By The Department Of Health And Human Services | Uses of 9-cis-retinoic acids and derivatives thereof alone or in combination with antineoplastic agents in the prevention or treatment of cancer |
| GB9509572D0 (en) | 1995-05-11 | 1995-07-05 | Cancer Res Campaign Tech | Cancer therapy |
| DE19526146A1 (de) * | 1995-07-07 | 1997-01-09 | Schering Ag | Triphenylethylene, Verfahren zu deren Herstellung, diese Triphenylethylene enthaltene pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln |
| JP2000503991A (ja) | 1996-01-29 | 2000-04-04 | イーライ・リリー・アンド・カンパニー | 括約筋受容能力を増大させる方法 |
| GB9604577D0 (en) | 1996-03-04 | 1996-05-01 | Orion Yhtymae Oy | Serum cholesterol lowering agent |
| KR20010029519A (ko) | 1996-09-19 | 2001-04-06 | 이곤 이 버그 | 요실금 치료 방법 |
| ZA982819B (en) * | 1997-04-09 | 1999-10-04 | Lilly Co Eli | Treatment or prophylaxis of prostatic cancer and benign prostatic hyperplasia with selective estrogn receptor modulators. |
| US5972921A (en) * | 1997-12-12 | 1999-10-26 | Hormos Medical Oy Ltd. | Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men |
| GB9803521D0 (en) | 1998-02-19 | 1998-04-15 | Orion Yhtymo Oy | New compounds and pharmaceutical compositions thereof |
| US6413533B1 (en) * | 1998-05-07 | 2002-07-02 | The University Of Tennessee Research Corporation | Method for chemoprevention of prostate cancer |
| US6413534B1 (en) * | 1998-05-07 | 2002-07-02 | The University Of Tennessee Research Corporation | Method for chemoprevention of prostate cancer |
| US6465445B1 (en) | 1998-06-11 | 2002-10-15 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| AU4701299A (en) * | 1998-06-23 | 2000-01-10 | Stuart R. Adler | Therapeutic applications of estrogenic carboxylic acids |
| CA2367895A1 (en) * | 1999-03-17 | 2000-09-21 | Signal Pharmaceuticals, Inc. | Compounds and methods for modulation of estrogen receptors |
| TW593256B (en) | 1999-11-16 | 2004-06-21 | Hormos Medical Oy Ltd | Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| AU2001271781A1 (en) | 2000-07-06 | 2002-01-21 | Wyeth | Use of substituted indole compounds for treating sphincter incontinence |
| IL145838A (en) | 2000-10-16 | 2008-11-03 | Pfizer Prod Inc | Use of an estrogen agonist/antagonist for the manufacture of a medicament for treating vaginitis |
| RU2184543C1 (ru) * | 2001-05-24 | 2002-07-10 | Московская медицинская академия им. И.М.Сеченова | Способ лечения хронического простатита |
| JP4301763B2 (ja) * | 2001-10-31 | 2009-07-22 | 藤倉化成株式会社 | 銀化合物ペースト |
| MXPA04003866A (es) | 2001-11-09 | 2004-07-08 | Pharmacia Ab | Agente-antimuscarnico y agonista de estrogeno para tratar la vejiga inestable o hiperactiva. |
| US20040248989A1 (en) * | 2003-06-05 | 2004-12-09 | Risto Santti | Method for the treatment or prevention of lower urinary tract symptoms |
-
2007
- 2007-05-22 KR KR1020087030717A patent/KR101505884B1/ko not_active Expired - Fee Related
- 2007-05-22 EP EP07734629.4A patent/EP2029128B1/en active Active
- 2007-05-22 CA CA2652783A patent/CA2652783C/en not_active Expired - Fee Related
- 2007-05-22 CN CNA2007800184357A patent/CN101448490A/zh active Pending
- 2007-05-22 RU RU2008150489/15A patent/RU2480207C2/ru active
- 2007-05-22 AU AU2007252991A patent/AU2007252991B2/en not_active Ceased
- 2007-05-22 MX MX2008014825A patent/MX2008014825A/es active IP Right Grant
- 2007-05-22 JP JP2009511598A patent/JP5123935B2/ja not_active Expired - Fee Related
- 2007-05-22 US US11/751,846 patent/US7825107B2/en not_active Expired - Fee Related
- 2007-05-22 BR BRPI0712103-2A patent/BRPI0712103A2/pt not_active Application Discontinuation
- 2007-05-22 ES ES07734629.4T patent/ES2551690T3/es active Active
- 2007-05-22 WO PCT/IB2007/001321 patent/WO2007135547A2/en not_active Ceased
-
2008
- 2008-11-18 NO NO20084822A patent/NO341185B1/no not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009537629A5 (enExample) | ||
| WO2007089571A8 (en) | Method of treating chronic kidney disease | |
| MY164900A (en) | Use of an alpha-adrenoceptor antagonist in combination with a muscarinic antagonist in the manufacture of a medicament for treating the lower urinary tract symptoms associated with benign prostatic hyperplasia | |
| NO2017019I2 (no) | Enzalutamid eller et farmasøytisk akseptabelt salt derav | |
| WO2005113816A3 (en) | Methods of diagnosing or treating prostate cancer using the erg gene, alone or in combination with other over or under expressed genes in prostate cancer | |
| CL2007001269A1 (es) | Compuestos derivados de heterociclos de nitrogeno, moduladores de vias de hedgehog; y uso para el tratamiento de cancer pancreatico, cancer de prostata, meduloblastoma, carcinoma celular basal y cancer pulmonar de celula pequena. | |
| TNSN08147A1 (en) | Pde inhibitors and combinations thereof for the treatment of urological disorders | |
| ME00937B (me) | Kombinovane terapije koje sadrže hinoksalinske inhibitore pi3k-alfa za upotrebu u liječenju kancera | |
| PL2559439T3 (pl) | Preparat farmaceutyczny do leczenia łagodnego rozrostu gruczołu krokowego | |
| WO2008058239A3 (en) | Spink1 as a prostate cancer marker and uses thereof | |
| JP2006517944A5 (enExample) | ||
| EP2034835A4 (en) | NONTOXIC CANCER WITH A COMBINATION OF ASCORBATE, MAGNESIUM AND A NAPHTHOCHINONE | |
| WO2008070472A3 (en) | Use of plasma hsp90 related to malignancy | |
| RU2008150489A (ru) | Способ лечения хронического абактериального простатита селективными модуляторами рецепторов эстрогена или ингибиторами ароматазы | |
| EP2722060A3 (en) | Guanylyl cyclase C ligands | |
| JP2011509956A5 (enExample) | ||
| EP2083840A4 (en) | IMPROVED TREATMENT FOR BENEFICIAL PROSTATE HYPERPLASIA | |
| JP2008534513A5 (enExample) | ||
| TW200630083A (en) | Use of a beta-3 agonist for the treatment of disorders of the prostate and of the lower urogenital tract | |
| UA56965U (ru) | Средство для лечения и профилактики доброкачественной гиперплазии предстательной железы, простатита, импотенции, бесплодия и paka предстательной железы | |
| WO2006005602A3 (en) | Use of ecteinascidin in the treatment of cancer in patients with low level of brca1 | |
| Rosenberg et al. | The signature operator at 2 | |
| BE1016292A3 (nl) | Verbinding en gebruik bij behandeling. | |
| WO2009045019A3 (en) | Composition and method for treatment or prevention of benign prostatic hyperplasia and lower urinary tract symptoms | |
| IL200899A0 (en) | Intravesical apaziquone administration following transurethral resection for treating cancer |